AFRM vs OGEN · P/E 590, rev $3.22B vs rev $37.7K
Affirm Holdings Inc (AFRM) versus Oragenics Inc (OGEN) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Oragenics Inc (OGEN) is a biotechnology company listed on US.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported OGEN revenue for 2023-12-31 was $37.7K. Net income was -$20.7M. Revenue was down 71.4% from 2022-12-31 to 2023-12-31. OGEN currently screens at market cap $2.7M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. OGEN currently screens at market cap $2.7M.
Not investment advice. Open the AFRM and OGEN stock pages for the full models.
Not investment advice.